Application 091008
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 100MG | No | No |
| 002 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 300MG | No | No |
| 003 | GABAPENTIN | GABAPENTIN | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091008-001 | GABAPENTIN | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-002 | GABAPENTIN | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | ||
| A091008-003 | GABAPENTIN | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-002 | GABAPENTIN | 300MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091008-003 | GABAPENTIN | 400MG | CAPSULE / ORAL | 2017-10-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091008-001 | GABAPENTIN | 100MG | CAPSULE / ORAL | 2017-10-26 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A091008-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091008-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A091008-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A091008-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A091008-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 235a6954-318a-9e3a-e063-6394a90a0e21 | 2026-06-19 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c9f0cceb-b24e-4526-b873-fedd877d6bc6 | 2026-06-18 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9a829dc3-b2d8-4d19-a579-0597217cec9b | 2026-06-17 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-06-11 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-06-08 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Coupler LLC | 5385e27c-f2fa-32d5-e063-6294a90a0a8c | 2026-06-05 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-06-04 | Warnings, Adverse reactions | Gabapentin GABAPENTIN |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 07f07d15-ee91-8c2a-e063-6394a90a4624 | 2026-06-03 | Warnings, Adverse reactions | GABAPENTIN GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2001 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2002 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Medicine Co. Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |
| 57884-2003 | Gabapentin | Gabapentin | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | ANDA | Current |